1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after each study vaccine dose with the exception of oral polio vaccine opv which can be give at any time and routine inactivate vaccine such a pneumococcal meningococcal or haemophilus|vaccine[139,146]|||||||30 day[93,99]|||11094|11094|vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after each study vaccine dose with the exception of oral polio vaccine opv which can be give at any time and routine inactivate vaccine such a pneumococcal meningococcal or haemophilus|vaccine[185,192]|||||oral[174,178]|||||11094|11094|vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after each study vaccine dose with the exception of oral polio vaccine opv which can be give at any time and routine inactivate vaccine such a pneumococcal meningococcal or haemophilus|meningococcal[278,291]|||||||||C2960908|1106215|1106215|meningococcal
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after each study vaccine dose with the exception of oral polio vaccine opv which can be give at any time and routine inactivate vaccine such a pneumococcal meningococcal or haemophilus|pneumococcal[265,277]|||||||||C0358314|106467|106467|pneumococcal vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after each study vaccine dose with the exception of oral polio vaccine opv which can be give at any time and routine inactivate vaccine such a pneumococcal meningococcal or haemophilus|vaccine[250,257]||||||||||11094|11094|vaccine
2	influenzae type b conjugate vaccine inactivate influenza or diphtheria/tetanus containing vaccine which can be administer up to eight day before each study vaccine dose|conjugate vaccine[325,342]||||||||||90039|90039|conjugate vaccine
2	influenzae type b conjugate vaccine inactivate influenza or diphtheria/tetanus containing vaccine which can be administer up to eight day before each study vaccine dose|vaccine[397,404]|||||||eight day[435,444]|||11094|11094|vaccine
2	influenzae type b conjugate vaccine inactivate influenza or diphtheria/tetanus containing vaccine which can be administer up to eight day before each study vaccine dose|vaccine[463,470]||||||||||11094|11094|vaccine
